bortezomib
(Bortezomib)Ingenus Pharmaceuticals, LLC
Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
4 results
kyprolis
(carfilzomib)Onyx Pharmaceuticals, Inc.Usage: Kyprolis is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma, specifically those who have undergone one to three lines of therapy. It can be used in combination with agents like lenalidomide or daratumumab, or as a single agent following prior therapies.ninlaro
(ixazomib)Takeda Pharmaceuticals America, Inc.Usage: NINLARO is indicated for use in combination with lenalidomide and dexamethasone to treat multiple myeloma in patients who have received at least one prior therapy. It is not recommended for maintenance therapy or in newly diagnosed cases outside clinical trials.velcade
(bortezomib)Takeda Pharmaceuticals America, Inc.Usage: VELCADE is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.